The county has trained librarians, food bank volunteers, local pharmacy staff and others to assist people in using C-IV
and kiosk applications.
With the implementation in the four consortium counties now completed, a group of 35 other counties currently using an older welfare system known as ISAWS and the State are investigating how to transition to the C-IV
Intermezzo (zolpidem tartrate) sublingual tablet C-IV
is the first FDA approved Transcept product and is indicated for use as needed for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep.
Knoll Pharmaceutical Company is the maker of MERIDIA(R) (sibutramine hydrochloride monohydrate) C-IV
Capsules, an FDA-approved oral medication used for the medical management of obesity, including weight loss and the maintenance of weight loss.
For more information about Meridia (sibutramine HCL monohydrate) C-IV
, including full prescribing information, please visit http://www.
Meridia(R) (sibutramine HCI monohydrate) C-IV
Use and Safety Information
NASDAQ: IPIC) today announced the finalization of a three-year co-promotion agreement with Wyeth-Ayerst Laboratories, a division of American Home Products (NYSE:AHP), in connection with today's launch of Redux (dexfenfluramine hydrochloride capsules) C-IV
for marketing as prescription therapy for the management of obesity.
Food and Drug Administration (FDA) has cleared Redux (dexfenfluramine hydrochloride capsules) C-IV
for marketing as prescription therapy for the management of obesity, including weight loss and maintenance of weight loss in patients on a reduced calorie diet.
Food and Drug Administration approval to ship Pemoline C-IV
tablets, a stimulant drug used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
11 /PRNewswire/ -- In regard to the article appearing in today's Wall Street Journal, Wyeth-Ayerst reaffirms that it appropriately assessed all Belgian adverse drug event reports it received for Pondimin (fenfluramine hydrochloride) tablets C-IV
and Redux (dexfenfluramine hydrochloride capsules) C-IV
, and submitted to the FDA those that were reportable under FDA regulations.
, today announced a voluntary and immediate withdrawal of
Redux(TM) (dexfenfluramine hydrochloride capsules) C-IV